Agilent Technologies Inc. (NYSE: A) announced today that it will present a range of next‑generation automated workflow ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR 1 ...

Agilent stands out as a focused, well-managed leader in life science instruments, with strong financials and resilience amid global trade headwinds. The Ignite transformation program enhances supply ...

Agilent has agreed to acquire Biovectra for $925 million, the companies said today, in a deal intended to expand the buyer’s contract development and manufacturing (CDMO) portfolio to the production ...

Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2026 after the stock market closes on Wednesday, Feb. 25. The company will host a conference ...

Agilent has boosted its contract development and manufacturing organisation (CDMO) capacity with a $925 million deal to buy Biovectra, a Canadian provider of fill-and-finish services and active ...

As with many other companies Agilent Technologies, Inc. (NYSE:A) makes use of debt. But should shareholders be worried about its use of debt? We've found 21 US stocks that are forecast to pay a ...

Life sciences tools company Agilent Technologies (NYSE:A) reported Q1 CY2025 results , with sales up 6% year on year to $1.67 billion. Guidance for next quarter’s revenue was better than expected at ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing ...

Agilent is a wonderful business with a strong competitive moat, decent growth, and excellent profitability. The company benefits from customer "stickiness" and growth in the biopharmaceutical sector.

It has been about a month since the last earnings report for Agilent Technologies (A). Shares have lost about 2.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Greg MacKenney, VP and general manager of supplies division at Agilent. Not many people these days can say that they’ve been with the same company for 24 years. Greg MacKenney is one of those who can.